We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Antitrust Authority: Actavis Inflated Prices of Hydrocortisone
UK Antitrust Authority: Actavis Inflated Prices of Hydrocortisone
UK’s antitrust agency has accused Actavis of breaching competition law by raising the price of generic hydrocortisone tablets for Addison’s disease by more than 12,000 percent since 2008.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor